Apoptosis and cytotoxicity of oligo(styrene-co-acrylonitrile)-modified montmorillonite

Applied Clay Science

Volumn 51, Issue 3, 2011, Pages 214-219

  Liu, Qian ^a   Liu, Yachun ^a   Xiang, Shuanglin ^a   Mo, Xiaojun ^a   Su, Shengpei ^a   Zhang, Jian ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cytotoxicity; Montmorillonite; Oligo(styrene co acrylonitrile)

Indexed keywords

APOPTOSIS; CASPASE-3; CONTROLLED RELEASE; CYTOTOXIC; CYTOTOXIC EFFECTS; DRUG MOLECULES; GENE DELIVERY; LACTATE DEHYDROGENASE; MODIFIED MONTMORILLONITE; MONTMORILLONITE; MRNA LEVEL; OLIGO(STYRENE-CO-ACRYLONITRILE); P53 AND P21; PRO-APOPTOTIC GENES; TRANSCRIPTIONAL ACTIVITY;

CELL DEATH; CLAY MINERALS; CONTROLLED DRUG DELIVERY; GENE THERAPY; GENE TRANSFER; SILICATE MINERALS; STYRENE; TRANSCRIPTION;

CYTOTOXICITY;

APOPTOSIS; CYTOLOGY; ENZYME ACTIVITY; MONTMORILLONITE; TOXICITY;

EID: 79251600492     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.11.019     Document Type: Article

References (33)

1. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Applied Clay Science 2007, 36:22-36.
2. Bekçi Z., Seki Y., Kadir Yurdakoç M. A study of equilibrium and FTIR, SEM/EDS analysis of trimethoprim adsorption onto K10. Journal of Molecular Structure 2007, 827:67-74.
3. Bonina F.P., Giannossi M.L., Medici L., Puglia C., Summa V., Tateo F. Adsorption of salicylic acid on bentonite and kaolin and release experiments. Applied Clay Science 2007, 36:77-85.
4. Carretero M.I. Clay minerals and their beneficial effects upon human health. A review. Applied Clay Science 2002, 21:155-163.
5. Carretero M.I., Pozo M. Clay and non-clay minerals in the pharmaceutical industry: Part I. Excipients and medical applications. Applied Clay Science 2009, 46:73-80.
6. Chen R., Chen D., Su S. Synthesis and characterization of novel oligomeric poly(styrene-co-acrylonitrile)-clay complexes. Journal of Applied Polymer Science 2009, 112:3355-3361.
7. Darder M., Colilla M., Ruiz Hitzky E. Biopolymer-clay nanocomposites based on chitosan intercalated in montmorillonite. Chemistry of Materials 2003, 15:3774-3780.
8. de Paiva L.B., Morales A.R., Valenzuela Díaz F.R. Organoclays: properties, preparation and applications. Applied Clay Science 2008, 42:8-24.
9. DeRosa F., Kibbe M.R., Najjar S.F., Citro M.L., Keefer L.K., Hrabie J.A. Nitric oxide-releasing fabrics and other acrylonitrile-based diazeniumdiolates. Journal of the American Chemical Society 2007, 129:3786-3787.
10. Dong Y., Feng S.S. Poly(d, l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:6068-6076.
11. Fan T.J., Han L.H., Cong R.S., Liang J. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica (Shanghai) 2005, 37:719-727.
12. Fejér I., Kata M., Erös I., Berkesi O., Dékány I. Release of cationic drugs from loaded clay minerals. Colloid and Polymer Science 2001, 279:1177-1182.
13. Fejér I., Kata M., Erõs I., Dékány I. Interaction of monovalent cationic drugs with montmorillonite. Colloid and Polymer Science 2002, 280:372-379.
14. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 2009, 30:3297-3306.
15. He G., Siddik Z.H., Huang Z., Wang R., Koomen J., Kobayashi R., Khokhar A.R., Kuang J. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 2005, 24:2929-2943.
16. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. International Journal of Pharmaceutics 2009, 374:53-57.
17. Joshi G.V., Patel H.A., Kevadiya B.D., Bajaj H.C. Montmorillonite intercalated with vitamin B1 as drug carrier. Applied Clay Science 2009, 45:248-253.
18. Kollár T., Pálinkó I., Kónya Z., Kiricsi I. Intercalating amino acid guests into montmorillonite host. Journal of Molecular Structure 2003, 651-653:335-340.
19. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
20. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23:1981-1987.
21. Lin F.H., Chen C.H., Cheng W.T.K., Kuo T.F. Modified montmorillonite as vector for gene delivery. Biomaterials 2006, 27:3333-3338.
22. López Galindo A., Viseras C., Cerezo P. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Applied Clay Science 2007, 36:51-63.
23. Meng N., Zhou N.L., Zhang S.Q., Shen J. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite. International Journal of Pharmaceutics 2009, 382:45-49.
24. Millau J.F., Bastien N., Drouin R. P53 transcriptional activities: a general overview and some thoughts. Mutation Research 2009, 681:118-133.
25. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romão C.C., Calhorda M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. European Journal of Pharmaceutics and Biopharmaceutics 2007, 66:357-365.
26. Park J.K., Choy Y.B., Oh J.M., Kim J.Y., Hwang S.J., Choy J.H. Controlled release of donepezil intercalated in smectite clays. International Journal of Pharmaceutics 2008, 359:198-204.
27. Seki Y., Yurdakoç K. Adsorption of promethazine hydrochloride with KSF montmorillonite. Adsorption 2006, 12:89-100.
28. Sheikh M.S., Chen Y.Q., Smith M.L., Fornace A.J. Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 1997, 14:1875-1882.
29. Vicente M.A., Sanchez Camazano M., Sanchez Martin M.J., del Arco M., Martin C., Rives V., Vincente Hernandez V. Adsorption and desorption of N-methyl 8-hydroxy quinoline methyl sulfate on smectite and the potential use of the clay-organic product as an ultraviolet radiation collector. Clays and Clay Minerals 1989, 37:157-163.
30. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
31. Walden P.D., Globina Y., Nieder A. Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase. Urological Research 2004, 32:261-265.
32. Wang X., Du Y., Luo J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19:065707.
33. Zheng J.P., Luan L., Wang H.Y., Xi L.F., Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Applied Clay Science 2007, 36:297-301.